Evaluation of posaconazole plasma concentrations achieved with the delayed‐release tablets in Korean high‐risk patients with haematologic malignancy-Reference-Cited by-同舟云学术

Evaluation of posaconazole plasma concentrations achieved with the delayed‐release tablets in Korean high‐risk patients with haematologic malignancy

Published:2019-11-28 Issue:2 Volume:63 Page:131-138
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Chae Hyojin¹²^ORCID,Cho Sung‐Yeon³⁴⁵,Yi Yunmi³⁴⁵,Lee Jeong Joong¹,Cha Kyoungho¹,Kim Myungshin¹²,Kim Yonggoo¹²,Kim Yoo‐Jin⁵,Kim Hee‐Je⁵,Lee Dong‐Gun³⁴⁵^ORCID

Affiliation:

1. Department of Laboratory Medicine College of Medicine The Catholic University of Korea Seoul Republic of Korea

2. Catholic Laboratory Development and Evaluation Center College of Medicine The Catholic University of Korea Seoul Republic of Korea

3. Division of Infectious Diseases Department of Internal Medicine College of Medicine The Catholic University of Korea Seoul Republic of Korea

4. Vaccine Bio Research Institute College of Medicine The Catholic University of Korea Seoul Republic of Korea

5. Catholic Hematology Hospital College of Medicine The Catholic University of Korea Seoul Republic of Korea

Funder

Merck Sharp and Dohme

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13031

Reference23 articles.

1. Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

2. Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease

3. Determination of posaconazole concentration with LC–MS/MS in adult patients with hematologic malignancy

4. Hot Melt Extruded Amorphous Solid Dispersion of Posaconazole with Improved Bioavailability: Investigating Drug-Polymer Miscibility with Advanced Characterisation

5. Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches for posaconazole therapeutic drug monitoring and their clinical benefits;European Journal of Clinical Pharmacology;2024-09-09

2. Evaluation of Posaconazole Serum Concentrations Achieved With Delayed-release Tablets and Oral Suspension in Patients Undergoing Intensive Chemotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome;Open Forum Infectious Diseases;2024-04-26

3. Factors Influencing Serum Posaconazole Concentrations in Patients With Hematologic Malignancies Receiving Delayed-Release Tablets;Therapeutic Drug Monitoring;2024-04-04

4. Yinhuang oral liquid protects acetaminophen-induced acute liver injury by regulating the activation of autophagy and Nrf2 signaling;Ecotoxicology and Environmental Safety;2022-10

5. Antifungal Drugs TDM: Trends and Update;Therapeutic Drug Monitoring;2022-02